HEADER TRANSCRIPTION REGULATOR/INHIBITOR 31-MAY-17 5W0Q TITLE CREBBP BROMODOMAIN IN COMPLEX WITH CPD17 (N,2,7-TRIMETHYL-2,3-DIHYDRO- TITLE 2 4H-BENZO[B][1,4]OXAZINE-4-CARBOXAMIDE) COMPND MOL_ID: 1; COMPND 2 MOLECULE: CREB-BINDING PROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: BROMODOMAIN, UNP RESIDUES 1082-1197; COMPND 5 EC: 2.3.1.48; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CREBBP, CBP; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CREBBP, BROMODOMAIN, SMALL MOLECULE INHIBITOR, TRANSFERASE-INHIBITOR KEYWDS 2 COMPLEX, TRANSCRIPTION REGULATOR-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.M.MURRAY REVDAT 2 04-OCT-23 5W0Q 1 REMARK REVDAT 1 07-MAR-18 5W0Q 0 JRNL AUTH F.A.ROMERO,J.MURRAY,K.W.LAI,V.TSUI,B.K.ALBRECHT,L.AN, JRNL AUTH 2 M.H.BERESINI,G.DE LEON BOENIG,S.M.BRONNER,E.W.CHAN,K.X.CHEN, JRNL AUTH 3 Z.CHEN,E.F.CHOO,K.CLAGG,K.CLARK,T.D.CRAWFORD,P.CYR, JRNL AUTH 4 D.DE ALMEIDA NAGATA,K.E.GASCOIGNE,J.L.GROGAN, JRNL AUTH 5 G.HATZIVASSILIOU,W.HUANG,T.L.HUNSAKER,S.KAUFMAN,S.G.KOENIG, JRNL AUTH 6 R.LI,Y.LI,X.LIANG,J.LIAO,W.LIU,J.LY,J.MAHER,C.MASUI, JRNL AUTH 7 M.MERCHANT,Y.RAN,A.M.TAYLOR,J.WAI,F.WANG,X.WEI,D.YU,B.Y.ZHU, JRNL AUTH 8 X.ZHU,S.MAGNUSON JRNL TITL GNE-781, A HIGHLY ADVANCED POTENT AND SELECTIVE BROMODOMAIN JRNL TITL 2 INHIBITOR OF CYCLIC ADENOSINE MONOPHOSPHATE RESPONSE ELEMENT JRNL TITL 3 BINDING PROTEIN, BINDING PROTEIN (CBP). JRNL REF J. MED. CHEM. V. 60 9162 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 28892380 JRNL DOI 10.1021/ACS.JMEDCHEM.7B00796 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX DEV_2747 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.78 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 16383 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.189 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.213 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.090 REMARK 3 FREE R VALUE TEST SET COUNT : 834 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 24.7771 - 3.0878 0.96 2650 144 0.1734 0.2031 REMARK 3 2 3.0878 - 2.4516 1.00 2653 124 0.1969 0.1931 REMARK 3 3 2.4516 - 2.1419 1.00 2603 149 0.1840 0.2206 REMARK 3 4 2.1419 - 1.9461 1.00 2597 134 0.1951 0.2413 REMARK 3 5 1.9461 - 1.8067 1.00 2585 145 0.2110 0.2391 REMARK 3 6 1.8067 - 1.7002 0.95 2461 138 0.2293 0.2400 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.140 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.060 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.51 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.42 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 1031 REMARK 3 ANGLE : 0.587 1401 REMARK 3 CHIRALITY : 0.043 143 REMARK 3 PLANARITY : 0.005 179 REMARK 3 DIHEDRAL : 13.785 615 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 6.9391 18.0901 -14.0557 REMARK 3 T TENSOR REMARK 3 T11: 0.1449 T22: 0.1308 REMARK 3 T33: 0.1274 T12: 0.0099 REMARK 3 T13: 0.0141 T23: -0.0360 REMARK 3 L TENSOR REMARK 3 L11: 3.1635 L22: 1.9391 REMARK 3 L33: 2.1842 L12: 0.8109 REMARK 3 L13: 0.7753 L23: 0.7220 REMARK 3 S TENSOR REMARK 3 S11: 0.0203 S12: 0.1872 S13: -0.2477 REMARK 3 S21: -0.0962 S22: -0.0172 S23: 0.0375 REMARK 3 S31: 0.1489 S32: -0.0339 S33: 0.0011 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5W0Q COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-JUN-17. REMARK 100 THE DEPOSITION ID IS D_1000228242. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-MAY-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16387 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 24.775 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.07200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.55600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5I8B REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.08 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.09 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M BIS-TRIS PH 6.5, 0.2M LI2SO4, 25% REMARK 280 PEG3350, VAPOR DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 24.55950 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 27.93100 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 53.64900 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 24.55950 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 27.93100 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 53.64900 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 24.55950 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 27.93100 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 53.64900 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 24.55950 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 27.93100 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 53.64900 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 300 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7360 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 S SO4 A1201 LIES ON A SPECIAL POSITION. REMARK 375 O4 SO4 A1201 LIES ON A SPECIAL POSITION. REMARK 375 S SO4 A1202 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1050 REMARK 465 HIS A 1051 REMARK 465 HIS A 1052 REMARK 465 HIS A 1053 REMARK 465 HIS A 1054 REMARK 465 HIS A 1055 REMARK 465 HIS A 1056 REMARK 465 GLY A 1057 REMARK 465 SER A 1058 REMARK 465 LEU A 1059 REMARK 465 VAL A 1060 REMARK 465 PRO A 1061 REMARK 465 ARG A 1062 REMARK 465 GLY A 1063 REMARK 465 SER A 1064 REMARK 465 MET A 1065 REMARK 465 ASP A 1066 REMARK 465 TYR A 1067 REMARK 465 LYS A 1068 REMARK 465 ASP A 1069 REMARK 465 ASP A 1070 REMARK 465 ASP A 1071 REMARK 465 ASP A 1072 REMARK 465 LYS A 1073 REMARK 465 GLU A 1074 REMARK 465 ASN A 1075 REMARK 465 LEU A 1076 REMARK 465 TYR A 1077 REMARK 465 PHE A 1078 REMARK 465 GLN A 1079 REMARK 465 GLY A 1080 REMARK 465 SER A 1081 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 1203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9UG A 1204 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5W0L RELATED DB: PDB DBREF 5W0Q A 1082 1197 UNP Q92793 CBP_HUMAN 1082 1197 SEQADV 5W0Q MET A 1050 UNP Q92793 INITIATING METHIONINE SEQADV 5W0Q HIS A 1051 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q HIS A 1052 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q HIS A 1053 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q HIS A 1054 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q HIS A 1055 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q HIS A 1056 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q GLY A 1057 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q SER A 1058 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q LEU A 1059 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q VAL A 1060 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q PRO A 1061 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q ARG A 1062 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q GLY A 1063 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q SER A 1064 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q MET A 1065 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q ASP A 1066 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q TYR A 1067 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q LYS A 1068 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q ASP A 1069 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q ASP A 1070 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q ASP A 1071 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q ASP A 1072 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q LYS A 1073 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q GLU A 1074 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q ASN A 1075 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q LEU A 1076 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q TYR A 1077 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q PHE A 1078 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q GLN A 1079 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q GLY A 1080 UNP Q92793 EXPRESSION TAG SEQADV 5W0Q SER A 1081 UNP Q92793 EXPRESSION TAG SEQRES 1 A 148 MET HIS HIS HIS HIS HIS HIS GLY SER LEU VAL PRO ARG SEQRES 2 A 148 GLY SER MET ASP TYR LYS ASP ASP ASP ASP LYS GLU ASN SEQRES 3 A 148 LEU TYR PHE GLN GLY SER LYS LYS ILE PHE LYS PRO GLU SEQRES 4 A 148 GLU LEU ARG GLN ALA LEU MET PRO THR LEU GLU ALA LEU SEQRES 5 A 148 TYR ARG GLN ASP PRO GLU SER LEU PRO PHE ARG GLN PRO SEQRES 6 A 148 VAL ASP PRO GLN LEU LEU GLY ILE PRO ASP TYR PHE ASP SEQRES 7 A 148 ILE VAL LYS ASN PRO MET ASP LEU SER THR ILE LYS ARG SEQRES 8 A 148 LYS LEU ASP THR GLY GLN TYR GLN GLU PRO TRP GLN TYR SEQRES 9 A 148 VAL ASP ASP VAL TRP LEU MET PHE ASN ASN ALA TRP LEU SEQRES 10 A 148 TYR ASN ARG LYS THR SER ARG VAL TYR LYS PHE CYS SER SEQRES 11 A 148 LYS LEU ALA GLU VAL PHE GLU GLN GLU ILE ASP PRO VAL SEQRES 12 A 148 MET GLN SER LEU GLY HET SO4 A1201 5 HET SO4 A1202 5 HET SO4 A1203 5 HET 9UG A1204 16 HETNAM SO4 SULFATE ION HETNAM 9UG (2R)-N,2,7-TRIMETHYL-2,3-DIHYDRO-4H-1,4-BENZOXAZINE-4- HETNAM 2 9UG CARBOXAMIDE FORMUL 2 SO4 3(O4 S 2-) FORMUL 5 9UG C12 H16 N2 O2 FORMUL 6 HOH *121(H2 O) HELIX 1 AA1 LYS A 1086 ARG A 1103 1 18 HELIX 2 AA2 SER A 1108 ARG A 1112 5 5 HELIX 3 AA3 ASP A 1116 GLY A 1121 1 6 HELIX 4 AA4 ASP A 1124 VAL A 1129 1 6 HELIX 5 AA5 ASP A 1134 THR A 1144 1 11 HELIX 6 AA6 GLU A 1149 ASN A 1168 1 20 HELIX 7 AA7 SER A 1172 GLY A 1197 1 26 CISPEP 1 ASP A 1105 PRO A 1106 0 5.42 SITE 1 AC1 2 ARG A1112 HOH A1386 SITE 1 AC2 2 ARG A1169 HOH A1347 SITE 1 AC3 3 SER A1172 ARG A1173 HOH A1301 SITE 1 AC4 6 PRO A1110 PHE A1111 LEU A1119 ASN A1168 SITE 2 AC4 6 HOH A1309 HOH A1365 CRYST1 49.119 55.862 107.298 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020359 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017901 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009320 0.00000